A review of mathematical models for leukemia and lymphoma
作者： Geoffrey Clapp , Doron Levy
DOI: 10.1016/J.DDMOD.2014.10.002
关键词:
摘要: Recently, there has been significant activity in the mathematical community, aimed at developing quantitative tools for studying leukemia and lymphoma. Mathematical models have applied to evaluate existing therapies suggest novel therapies. This article reviews recent contributions of modeling lymphoma research. These developments that great potential this field. Collaboration between mathematicians, clinicians, experimentalists can significantly improve therapy.
elsevier.com
sci-hub.se 参考文章(37)
Maite Silva, Didier Grillot, Adalberto Benito, Carlos Richard, Gabriel Nunez, Jose Luis Fernandez-Luna, Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2 Blood. ,vol. 88, pp. 1576- 1582 ,(1996) , 10.1182/BLOOD.V88.5.1576.1576
Anna Marciniak-Czochra, Thomas Stiehl, Anthony D. Ho, Willi Jäger, Wolfgang Wagner, Modeling of asymmetric cell division in hematopoietic stem cells--regulation of self-renewal is essential for efficient repopulation. Stem Cells and Development. ,vol. 18, pp. 377- 385 ,(2009) , 10.1089/SCD.2008.0143
Kevin Leder, Jasmine Foo, Brian Skaggs, Mercedes Gorre, Charles L. Sawyers, Franziska Michor, Fitness conferred by BCR-ABL kinase domain mutations determines the risk of pre-existing resistance in chronic myeloid leukemia. PLOS ONE. ,vol. 6, ,(2011) , 10.1371/JOURNAL.PONE.0027682
John C. Panetta, Alex Sparreboom, Ching-Hon Pui, Mary V. Relling, William E. Evans, Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells. PLOS Computational Biology. ,vol. 6, ,(2010) , 10.1371/JOURNAL.PCBI.1001019
Ingo Roeder, Maria Herberg, Matthias Horn, An “Age” Structured Model of Hematopoietic Stem Cell Organization with Application to Chronic Myeloid Leukemia Bulletin of Mathematical Biology. ,vol. 71, pp. 602- 626 ,(2009) , 10.1007/S11538-008-9373-7
I Glauche, K Horn, M Horn, L Thielecke, M AG Essers, A Trumpp, I Roeder, Therapy of chronic myeloid leukaemia can benefit from the activation of stem cells: simulation studies of different treatment combinations. British Journal of Cancer. ,vol. 106, pp. 1742- 1752 ,(2012) , 10.1038/BJC.2012.142
C Tomasetti, A new hypothesis: imatinib affects leukemic stem cells in the same way it affects all other leukemic cells Blood Cancer Journal. ,vol. 1, pp. e19- e19 ,(2011) , 10.1038/BCJ.2011.17
Jens Klaus, Doris Herrmann, Iris Breitkreutz, Ute Hegenbart, Uta Mazitschek, Gerlinde Egerer, Friedrich W. Cremer, Ray M. Lowenthal, Johannes Huesing, Stefan Fruehauf, Thomas Moehler, Anthony D. Ho, Hartmut Goldschmidt, Effect of CD34+ cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation European Journal of Haematology. ,vol. 78, pp. 21- 28 ,(2007) , 10.1111/J.0902-4441.2006.T01-1-EJH2895.X
Matthew Matasar, Word, Advances in the diagnosis and management of lymphoma Blood and Lymphatic Cancer: Targets and Therapy. ,vol. 2, pp. 29- 55 ,(2012) , 10.2147/BLCTT.S15554
C. Tomasetti, D. Levy, Role of symmetric and asymmetric division of stem cells in developing drug resistance Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 16766- 16771 ,(2010) , 10.1073/PNAS.1007726107